Clinical Trial Update: Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating resection of pulmonary metastases in clear cell renal cell carcinoma with or without adjuvant sunitinib therapy (SMAT…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Metastases
• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Association of Urologic Oncology (AUO) | Conditions: Renal Cell Carcinoma, Pulmonary Metastases | Phase 2 | Status: UNKNOWN